Q4 2024 Holdings
Filed 2025-04-08 | 8 holdings | $102.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $80.3M | 1,047,557 | 78.2% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $18.4M | 457,059 | 17.9% |
| Seer Inc(SEER) | COM CL A | 81578P106 | $1.9M | 816,375 | 1.8% |
| Rallybio Corp | COM | 75120L100 | $724.5K | 754,678 | 0.7% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T100 | $637.7K | 667,742 | 0.6% |
| Sutro Biopharma Inc | COM | 869367102 | $322.0K | 175,000 | 0.3% |
| Carisma Therapeutics Inc(CARM) | COM | 14216R101 | $300.8K | 718,332 | 0.3% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $157.2K | 99,503 | 0.2% |